维普期刊资源整合服务平台（V6.5）

84篇 您的检索式：作者名="Oosterwijk"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Basic research inkidney cancer显示文摘	Oosterwijk E Rathmell WK Junker K	2011	Eur Urol2011，60，4：	1
2	Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250labeled with 131I and 111I:an intrapatient comparison显示文摘	Brouwers AH Buijs WC Oosterwijk E	2003	Clin Cancer Res2003，9，10：	1
3	Prognostic impact ofcarbonic anhydrase IX expression in human renal cell carcinoma显示文摘	Sandlund J Oosterwijk E Grankvist K	2007	BJU International2007，100，3：	1
4	A phaseⅡtrial of chi-meric monoclonal antibody G250 for advanced renal cell carcinomapatients显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，5：	1
5	A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin--2 pulsing scheme for advanced renal cell carcinoma显示文摘	Bleumer I Oosterwijk E Oosterwijk-Wakka JO et aI	2006	J Urol2006，175，1：	1
6	Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFI3 as potential targets 显示文摘	Van Oosterwijk JG Meijer D van Ruler MA	2013	Am J Pathol2013，，：	1
7	Develop- ment of a partition-controlled dosing system for cell assays 显示文摘	Kramer N I Busser F J Oosterwijk M T	2010	Chemical Research in Toxicology2010，23，11：	1
8	Oral two-generation reproduction toxicity study with NM- 200 synthetic amorphous silica in wistar rats显示文摘	Wolterbeek A Oosterwijk T Schneider S	2015	Re- prod Toxico12015，56，：	1
9	Immunotherapy for renal cell carcinoma显示文摘	Bteumer I Oosterwijk E DeMulder P	2003	Eur Urol2003，44，1：	1
10	Immunotherapy for renal cell carcinoma显示文摘	Bleumer I Oosterwijk E De Mulder P	2003	EurUrol2003，44，1：	1
11	Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney显示文摘	Oosterwijk E Ruiter DJ Hoedemaeker PJ	1986	Int J Cancer1986，38，4：	1
12	Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with ( 131 ) Ⅰ or ( 111 ) In: an intrapatient comparison 显示文摘	Brouwers AH Buijs WC Oosterwijk E	2003	Clin Cancer Res2003，9，102：	1
13	Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney 显示文摘	Oosterwijk E Ruiter D J Hoedemaker PJ	1986	Int J Cancer1986，38，4：	1
14	Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney显示文摘	Oosterwijk E Ruiter D J Hoedemaeker P J	1986	Int J Cancer1986，38，4：	1
15	Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indiumlabeled diethylenetriaminepentaacetic acid antibody显示文摘	van Schaijk FG Oosterwijk E Soede AC	2005	Clin Cancer Res2005，11，192：	1
16	A phase Ⅱ trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients显示文摘	Bleumer I Knuth A Oosterwijk E	2004	Br J Cancer2004，90，：	1
17	Pretargeting with labelel Bivalant Peptides A1lowing the Use of Four Radionu clides:^111In,^131I,^99mTc,and ^188Re显示文摘	FG Schaijk E Oosterwijk AC Soede	2003	Clin Cancer Res2003，9，：	1
18	Monoclonal antibody G250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney显示文摘	Oosterwijk E Ruiter DJ Hoedemaker PJ	1986	Inf J Cancer1986，38，5：	1
19	Overexpression of carbonic anhydrase Ⅸ (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer 显示文摘	Choschzick M Oosterwijk E MUller V	2011	Virchows Arch2011，459，2：	1
20	Congenital abnor-malities reported in Pelger-Huet homozygosity as compared toGreenberg/HEM dysplasia:highly variable expression of allelicphenotypes显示文摘	Oosterwijk J C Mansour S van Noort G	2003	J Med Genet2003，，40：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示